| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 Departments of Pharmacology and Medicine, Medical University of South Carolina, Charleston, South Carolina 29425; 2 Department of Pharmacology and Toxicology, Military Medical Academy, Belgrade, FR Yugoslavia 11030; 3 Unidade de Hipertensao-Heart Institute (InCor), Hospital das Clinicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil 05403; and 4 Departments of Medicine and Pharmacology, William S. Middleton Veterans Memorial Hospital, University of Wisconsin, Madison, Wisconsin 53705
Evidence suggests lipid abnormalities may contribute to elevated blood pressure, increased vascular resistance, and reduced arterial compliance among insulin-resistant subjects. In a study of 11 normal volunteers undergoing 4-h-long infusions of Intralipid and heparin to raise plasma nonesterified fatty acids (NEFAs), we observed increases of blood pressure. In contrast, blood pressure did not change in these same volunteers during a 4-h infusion of saline and heparin. To better characterize the hemodynamic responses to Intralipid and heparin, another group of 21 individuals, including both lean and obese volunteers, was studied after 3 wk on a controlled diet with 180 mmol sodium/day. Two and four hours after starting the infusions, plasma NEFAs increased by 134 and 111% in those receiving Intralipid and heparin, P < 0.01, whereas plasma NEFAs did not change in the first group of normal volunteers who received saline and heparin. The hemodynamic changes in lean and obese subjects in the second study were similar, and the results were combined. The infusion of Intralipid and heparin induced a significant increase in systolic (13.5 ± 2.1 mmHg) and diastolic (8.0 ± 1.5 mmHg) blood pressure as well as heart rate (9.4 ± 1.4 beats/min). Small and large artery compliance decreased, and systemic vascular resistance rose. These data raise the possibility that lipid abnormalities associated with insulin resistance contribute to the elevated blood pressure and heart rate as well as the reduced vascular compliance observed in subjects with the cardiovascular risk factor cluster.
hypertension; nonesterified fatty acids; blood pressure
This article has been cited by other articles:
|
|
 |
|
  A. C. Inyard, D. G. Chong, A. L. Klibanov, and E. J. Barrett Muscle Contraction, but Not Insulin, Increases Microvascular Blood Volume in the Presence of Free Fatty Acid-Induced Insulin Resistance Diabetes, November 1, 2009; 58(11): 2457 - 2463. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Santosa and M. D. Jensen Why are we shaped differently, and why does it matter? Am J Physiol Endocrinol Metab, September 1, 2008; 295(3): E531 - E535. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. E. Hafidi, I. Perez, J. Zamora, V. Soto, G. Carvajal-Sandoval, and G. Banos Glycine intake decreases plasma free fatty acids, adipose cell size, and blood pressure in sucrose-fed rats Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2004; 287(6): R1387 - R1393. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Nielsen, J. R. Halliwill, M. J. Joyner, and M. D. Jensen Vascular Response to Angiotensin II in Upper Body Obesity Hypertension, October 1, 2004; 44(4): 435 - 441. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Vincent, B. Bouchard, M. Khairallah, and C. Des Rosiers Differential modulation of citrate synthesis and release by fatty acids in perfused working rat hearts Am J Physiol Heart Circ Physiol, January 1, 2004; 286(1): H257 - H266. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
